Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;30(1):121-123.
doi: 10.3350/cmh.2023.0437. Epub 2023 Dec 4.

Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD

Shuhei Fukunaga  1 , Michita Mukasa  1 , Dan Nakano  1 , Tsubasa Tsutsumi  1 , Takumi Kawaguchi  1
Affiliations

Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD

Shuhei Fukunaga et al. Clin Mol Hepatol. 2024 Jan.
No abstract available

Keywords: Gastroesophageal reflux disease; Metabolic; Steatosis; Steatotic liver disease.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

Takumi Kawaguchi received lecture fees from Janssen Pharmaceutical K.K., Taisho Pharmaceutical Co., Ltd., Kowa Company, Ltd., Otsuka Pharmaceutical Co., Ltd., Eisai Co., Ltd., ASKA Pharmaceutical Co., Ltd., AbbVie GK., and EA Pharma Co., Ltd. The other authors have no conflicts of interest.

Figures

Figure 1.
Figure 1.
Cumulative incidence of reflux esophagitis in the non-SLD, NAFLD, and MASLD groups. SLD, steatotic liver disease; NAFLD, nonalcoholic fatty liver disease; MASLD, metabolic dysfunction-associated steatotic liver disease.
See this image and copyright information in PMC

References

    1. Lazarus JV, Newsome PN, Francque SM, Kanwal F, Terrault NA, Rinella ME. Reply: A multi-society delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023 Nov 20. doi: 10.1097/HEP.0000000000000696. - PubMed
    1. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63:871–880. - PMC - PubMed
    1. Jansson C, Nordenstedt H, Wallander MA, Johansson S, Johnsen R, Hveem K, et al. Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a populationbased study. Aliment Pharmacol Ther. 2007;26:683–691. - PubMed
    1. Fuller G, Bolus R, Whitman C, Talley J, Erder MH, Joseph A, et al. PRISM, a patient-reported outcome instrument, accurately measures symptom change in refractory gastroesophageal reflux disease. Dig Dis Sci. 2017;62:593–606. - PubMed
    1. Fujiwara Y, Machida A, Watanabe Y, Shiba M, Tominaga K, Watanabe T, et al. Association between dinner-to-bed time and gastro-esophageal reflux disease. Am J Gastroenterol. 2005;100:2633–2636. - PubMed

MeSH terms